Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$dmac](/topic/$dmac)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$dmac/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$dmac/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1-Year High**: XXX% on 2025-06-26  
**1-Year Low**: XX% on 2025-07-18  

**Most Supportive Themes**
- **Bullish Sentiment and Price Targets:** (60%) Positive sentiment around $DMAC, with mentions of potential for significant gains and positive technical setups.
- **Stock Recommendations and Trading Strategies:** (30%) Mentions of $DMAC alongside other stocks that have shown recent gains, suggesting a positive correlation.
  
**Most Critical Themes**
- **Preeclampsia Drug Development:** (10%)  Concerns about the lack of FDA-approved drugs for preeclampsia and the potential impact of Phase X data on DM199.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$dmac

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1-Year High: XXX% on 2025-06-26
1-Year Low: XX% on 2025-07-18

Most Supportive Themes

  • Bullish Sentiment and Price Targets: (60%) Positive sentiment around $DMAC, with mentions of potential for significant gains and positive technical setups.
  • Stock Recommendations and Trading Strategies: (30%) Mentions of $DMAC alongside other stocks that have shown recent gains, suggesting a positive correlation.

Most Critical Themes

  • Preeclampsia Drug Development: (10%) Concerns about the lack of FDA-approved drugs for preeclampsia and the potential impact of Phase X data on DM199.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXX XX% XXX X%
Total XXXXX XX% XXXXX XX% XXX X%
$dmac Sentiment
/topic/$dmac/sentiment